• (PLX AI) – Novozymes Q3 sales DKK 3,761 million vs. estimate DKK 3,682 million.
  • • Q3 EBIT DKK 1,095 million vs. estimate DKK 913 million
  • • Q3 EBIT margin 29.1%
  • • Q3 net income DKK 843 million vs. estimate DKK 712 million
  • • Outlook FY organic growth 5-6%, up from 4-6% previously
  • • Outlook FY EBIT margin 27%, up from 26% previously
  • • ROIC incl. goodwill and FCF bef. acq. are raised to 20% to 21% and DKK 2.8 to 3.2 billion respectively
  • • CEO says momentum remains strong with double-digit organic sales growth in three of our five business areas, along with strong earnings

Quelle: PLX AI